Literature DB >> 28619557

Current and emerging treatments for vitiligo.

Michelle Rodrigues1, Khaled Ezzedine2, Iltefat Hamzavi3, Amit G Pandya4, John E Harris5.   

Abstract

Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.
Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Keywords:  afamelanotide; biologics; corticosteroids; excimer lamp; excimer laser; grafting; leukoderma; methotrexate; narrowband ultraviolet light; phototherapy; pigmentation; tacrolimus; treatment; vitiligo

Mesh:

Year:  2017        PMID: 28619557     DOI: 10.1016/j.jaad.2016.11.010

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  15 in total

Review 1.  The Role of Memory CD8+ T Cells in Vitiligo.

Authors:  Rebecca L Riding; John E Harris
Journal:  J Immunol       Date:  2019-07-01       Impact factor: 5.422

2.  scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in Treg function.

Authors:  Kyle J Gellatly; James P Strassner; Kingsley Essien; Maggi Ahmed Refat; Rachel L Murphy; Anthony Coffin-Schmitt; Amit G Pandya; Andrea Tovar-Garza; Michael L Frisoli; Xueli Fan; Xiaolan Ding; Evangeline E Kim; Zainab Abbas; Patrick McDonel; Manuel Garber; John E Harris
Journal:  Sci Transl Med       Date:  2021-09-08       Impact factor: 17.956

3.  Anatomically distinct fibroblast subsets determine skin autoimmune patterns.

Authors:  Zijian Xu; Daoming Chen; Yucheng Hu; Kaiju Jiang; Huanwei Huang; Yingxue Du; Wenbo Wu; Jiawen Wang; Jianhua Sui; Wenhui Wang; Long Zhang; Shuli Li; Chunying Li; Yong Yang; Jianmin Chang; Ting Chen
Journal:  Nature       Date:  2021-12-15       Impact factor: 49.962

4.  Inflammatory Vitiligo.

Authors:  Hua-Ching Chang; Chun-Yu Lai; Yin-Shuo Chang
Journal:  Dermatol Pract Concept       Date:  2022-07-01

5.  Relationship Between Depression and Quality of Life Among Vitiligo Patients: A Self-assessment Questionnaire-based Study.

Authors:  Narumol Silpa-Archa; Chutipon Pruksaeakanan; Nattha Angkoolpakdeekul; Chayada Chaiyabutr; Kanokvalai Kulthanan; Woraphat Ratta-Apha; Chanisada Wongpraparut
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-08-04

6.  Mouse Model for Human Vitiligo.

Authors:  Rebecca L Riding; Jillian M Richmond; John E Harris
Journal:  Curr Protoc Immunol       Date:  2018-09-25

7.  Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo.

Authors:  Jillian M Richmond; James P Strassner; Mehdi Rashighi; Priti Agarwal; Madhuri Garg; Kingsley I Essien; Lila S Pell; John E Harris
Journal:  J Invest Dermatol       Date:  2018-11-10       Impact factor: 8.551

8.  Microemulsions vs chitosan derivative-coated microemulsions for dermal delivery of 8-methoxypsoralen.

Authors:  Jun-Yong Wu; Yong-Jiang Li; Ting-Ting Liu; Ge Ou; Xiong-Bin Hu; Tian-Tian Tang; Jie-Min Wang; Xin-Yi Liu; Da-Xiong Xiang
Journal:  Int J Nanomedicine       Date:  2019-04-01

Review 9.  Updates and new medical treatments for vitiligo (Review).

Authors:  David Emmanuel Kubelis-López; Natalia Aranza Zapata-Salazar; Salvador Luis Said-Fernández; Celia Nohemí Sánchez-Domínguez; Mauricio Andrés Salinas-Santander; Herminia Guadalupe Martínez-Rodríguez; Osvaldo Tomás Vázquez-Martínez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

10.  Impact of treatment delays on vitiligo during the COVID-19 pandemic: A retrospective study.

Authors:  Xinya Xu; Chengfeng Zhang; Min Jiang; Leihong Flora Xiang
Journal:  Dermatol Ther       Date:  2021-06-16       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.